According to Annovis Bio's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โน4.82 Billion a decrease over its 2022 earnings that were of -โน1.78 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -โน3.42 Billion | -29.09% |
2023 | -โน4.82 Billion | 171.56% |
2022 | -โน1.78 Billion | 42.87% |
2021 | -โน1.25 Billion | 165.23% |
2020 | -โน0.47 Billion | 451.18% |
2019 | -โน84.92 Million | 38.82% |
2018 | -โน61.17 Million |